|
1
|
Jie L, Fan W, Weiqi D, Yingqun Z, Ling X,
Miao S, Ping C and Chuanyong G: The hippo-yes association protein
pathway in liver cancer. Gastroenterol Res Pract. 2013:1870702013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hong L, Cai Y, Jiang M, Zhou D and Chen L:
The Hippo signaling pathway in liver regeneration and
tumorigenesis. Acta Biochim Biophys Sin (Shanghai). 47:46–52. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu
J, Lin JD, Wang CY, Chinnaiyan AM, et al: TEAD mediates
YAP-dependent gene induction and growth control. Genes Dev.
22:1962–1971. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sudol M, Shields DC and Farooq A:
Structures of YAP protein domains reveal promising targets for
development of new cancer drugs. Semin Cell Dev Biol. 23:827–833.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Z, Hu T, Xu Z, et al: Targeting Hippo
pathway by specific interruption of YAP-TEAD interaction using
cyclic YAP-like peptides. FASEB J. 29:724–732. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size-control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu AM, Poon RT and Luk JM: MicroRNA-375
targets Hippo-signaling effector YAP in liver cancer and inhibits
tumor properties. Biochem Biophys Res Commun. 394:623–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kowalik MA, Saliba C, Pibiri M, Perra A,
Ledda-Columbano GM, Sarotto I, Ghiso E, Giordano S and Columbano A:
Yes-associated protein regulation of adaptive liver enlargement and
hepatocellular carcinoma development in mice. Hepatology.
53:2086–2096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perra A, Kowalik MA, Ghiso E,
Ledda-Columbano GM, Di Tommaso L, Angioni MM, Raschioni C, Testore
E, Roncalli M, Giordano S and Columbano A: YAP activation is an
early event and a potential therapeutic target in liver cancer
development. J Hepatol. 61:1088–1096. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou L, Qi X, Potashkin JA, Abdul-Karim FW
and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate
expression of the pro-apoptotic purinergic P2×7 receptor by
activation of instability sites at the 3′-untranslated region of
the gene that decrease steady-state levels of the transcript. J
Biol Chem. 283:28274–28286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Antoniou A, Mastroyiannopoulos NP, Uney JB
and Phylactou LA: miR-186 inhibits muscle cell differentiation
through myogenin regulation. J Biol Chem. 289:3923–3935. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang C, Zhang W, Chen HM, Liu C, Wu J,
Shi S and Liu ZH: Plasma MicroRNA-186 and proteinuria in focal
segmental glomerulosclerosis. Am J Kidney Dis. 65:223–232. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nadorp B and Soreq H: Predicted
overlapping microRNA regulators of acetylcholine packaging and
degradation in neuroinflammation-related disorders. Front Mol
Neurosci. 7:92014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ries J, Vairaktaris E, Agaimy A, Kintopp
R, Baran C, Neukam FW and Nkenke E: miR-186, miR-3651 and miR-494:
Potential biomarkers for oral squamous cell carcinoma extracted
from whole blood. Oncol Rep. 31:1429–1436. 2014.PubMed/NCBI
|
|
20
|
Li H, Yin C, Zhang B, Sun Y, Shi L, Liu N,
Liang S, Lu S, Liu Y, Zhang J, et al: PTTG1 promotes migration and
invasion of human non-small cell lung cancer cells and is modulated
by miR-186. Carcinogenesis. 34:2145–2155. 2013. View Article : Google Scholar : PubMed/NCBI
|
